Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
Holders of 5% or more of DWTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Dogwood Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Sealbond Ltd | 13D/A | 83.00%24.7M shares | +67.10 ppfrom 15.90% | Mar 17, 20252 filings | Nov 25, 2025 | SEC |
| Armistice Capital, LLC | 13G/A | 9.99%3.38M shares | 0.00 ppfrom 9.99% | May 15, 20262 filings | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Dogwood Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202610:10 AM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%3.38M shares | 0.00 ppfrom 9.99% | Jun 30, 2026 | SEC |
| May 15, 202611:13 AM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%3.34M shares | New | Mar 31, 2026 | SEC |
| Nov 25, 20255:30 PM ET | Sealbond Ltdand 2 others | 13D/A | 83.00%24.7M shares | +67.10 ppfrom 15.90% | Nov 21, 2025 | SEC |
| Mar 17, 20259:11 PM ET | Sealbond Ltdand 2 others | 13D/A | 15.90%211.4K shares | – | Mar 12, 2025 | SEC |
| Mar 17, 20255:53 PM ET | Orca Capital AG | 13G/A | 3.70%69.8K shares | −2.40 ppfrom 6.10%Below 5% | Mar 14, 2025 | SEC |
| Mar 17, 20255:49 PM ET | Orca Capital AG | 13G | 6.10%115.8K shares | New | Mar 12, 2025 | SEC |
| Feb 16, 2021 | Pridgen William | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Duncan Gregory Scott | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Burch Richard Alan | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Masters Capital Management LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Dogwood Therapeutics, Inc. shares.
No Form 144 notices for Dogwood Therapeutics, Inc. are on file.